CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy

Abstract Background Anamorelin is expected to improve cancer cachexia by increasing lean body mass (LBM) due to increased appetite and protein synthesis. However, the effect of anamorelin on cancer cachexia in real-world practice is unclear. The purpose of this study was to evaluate the efficacy and...

Cijeli opis

Bibliografski detalji

Glavni autori:	Hironori Fujii, Akitaka Makiyama, Kayoko Nishimura, Hirotoshi Iihara, Chiemi Hirose, Koichi Ohata, Yunami Yamada, Daichi Watanabe, Itaru Yasufuku, Naoki Okumura, Yoshihiro Tanaka, Takao Takahashi, Ryo Kobayashi, Nobuhisa Matsuhashi, Akio Suzuki
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-07-01
Serija:	Journal of Pharmaceutical Health Care and Sciences
Teme:	Cancer cachexia Anamorelin CONUT score Survival Performance status
Online pristup:	https://doi.org/10.1186/s40780-024-00359-5
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!